UTHR

United Therapeutics Corp
Data: 2026-07-31
$517.71
Price
-1.54%
Change
$609.35
52W High
$272.12
52W Low

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Quick Stats
Jul 31, 2026

48.4

AI Score

HOLD

0.85

Volume Ratio

Aug 05, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

UTHR Stock Summary

Last updated Jul 31, 2026

UTHR is currently trading at $517.71, positioned above its 200-day moving average of $514.33, indicating a long-term uptrend. The stock has a 52-week range of $272.12 to $609.35.

Technical Analysis: The 50-day moving average stands at $544.38, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.53, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.038, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates UTHR at 48.4/100 with a HOLD recommendation.

UTHR (United Therapeutics Corp) Indicators

Last updated Jul 31, 2026

Indicator Value
RSI(14) 36.53
CMF (20) -0.038
ROC (10) -3.353
ADX (14) 20.326
Indicator Value
MACD (12,26,9) -6.882
AROONOSC (14) -71.429
WILLAMS %R (14) -88.467
MFI (14) 43.476
UTHR Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

UTHR Price vs Max Options Open Interest
UTHR Max Change In Options Open Interest

UTHR Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

UTHR Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

UTHR Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

UTHR Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

United Therapeutics Corp is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

UTHR Moving Averages Analysis

United Therapeutics Corp has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 31, 2026

UTHR (United Therapeutics Corp) Simple Moving Averages

Moving Averages are last updated Jul 31, 2026

Days MA
10 527.0
20 534.68
30 537.95
50 544.38
100 553.51
200 514.33

UTHR Fundamental Analysis

P/E (Forward) 19.084
P/E (Trailing) 19.4245
Market Cap ($) 26.2 billion
Earnings/Share ($) 27.07
Net Profit Margin (%) 0.4062
Dividend/Share ($) --
EPS Estimate Current Year ($) 26.9187
EPS Estimate Next Year ($) 31.5121
WallStreet Target Price ($) 663.23
Most Recent Quarter